654
Participants
Start Date
January 31, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
October 31, 2018
tenofovir disoproxil fumarate
administration: tablet 300 mg, once a day, from enrollment at 28 weeks' gestation until 2 months postpartum
placebo
administration: one tablet, once a day, from enrollment at 28 weeks' gestation until 2 months postpartum
Bhumibol Adulyadej Hospital, Bangkok
Nopparat Rajathanee Hospital, Bangkok
Samutprakarn Hospital, Mueang Samut Prakan
Chonburi Regional Hospital, Chon Buri
Banglamung Hospital, Bang Lamung
Prapokklao Hospital, Chanthaburi
Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima
Khon Kaen Hospital, Khon Kaen
Health Promotion Center Region 10, Chiang Mai
Nakornping Hospital, Chiang Mai
Lamphun Hospital, Lamphun
Lampang Hospital, Lampang
Phayao Provincial Hospital, Phayao
Chiang Kham Hospital, Chiang Kham
Chiangrai Prachanukroh Hospital, Chiang Rai
Mae Chan Hospital, Mae Chan
Samutsakhon Hospital, Samut Sakhon
Collaborators (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Centers for Disease Control and Prevention
FED
Gilead Sciences
INDUSTRY
Institut de Recherche pour le Developpement
OTHER_GOV